U-Blot® Research Grade SpesolimabCat. No. WA3568Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SpesolimabCat. No. WA3568U-Blot® Research Grade SpartalizumabCat. No. WA3567Request quote
Size: 50ug/100ug
U-Blot® Research Grade SoziniberceptCat. No. WA3566Request quote
Size: 50ug/100ug
U-Blot® Research Grade sovipostobart betaCat. No. WA3565Request quote
Size: 50ug/100ug
U-Blot® Research Grade SovipostobartCat. No. WA3564Request quote
Size: 50ug/100ug
U-Blot® Research Grade SotrovimabCat. No. WA3563Request quote
Size: 50ug/100ug
U-Blot® Research Grade SotigalimabCat. No. WA3562Request quote
Size: 50ug/100ug
U-Blot® Research Grade Sotiburafusp AlfaCat. No. WA3561Request quote
Size: 50ug/100ug
U-Blot® Research Grade SotevtamabCat. No. WA3560Request quote
Size: 50ug/100ug
U-Blot® Research Grade SotaterceptCat. No. WA3559Request quote
Size: 50ug/100ug
U-Blot® Research Grade SontuzumabCat. No. WA3558Request quote
Size: 50ug/100ug
U-Blot® Research Grade sonesitatugCat. No. WA3557Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598